GB0113524D0 - Pyrazole derivatives - Google Patents

Pyrazole derivatives

Info

Publication number
GB0113524D0
GB0113524D0 GBGB0113524.3A GB0113524A GB0113524D0 GB 0113524 D0 GB0113524 D0 GB 0113524D0 GB 0113524 A GB0113524 A GB 0113524A GB 0113524 D0 GB0113524 D0 GB 0113524D0
Authority
GB
United Kingdom
Prior art keywords
compounds
pyrazole derivatives
concerned
inhibitors
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0113524.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to GBGB0113524.3A priority Critical patent/GB0113524D0/en
Publication of GB0113524D0 publication Critical patent/GB0113524D0/en
Priority to US10/154,585 priority patent/US6538015B1/en
Priority to BR0210158-0A priority patent/BR0210158A/pt
Priority to PCT/EP2002/005898 priority patent/WO2002100853A1/en
Priority to DK02758207T priority patent/DK1401826T3/da
Priority to PT02758207T priority patent/PT1401826E/pt
Priority to AT02758207T priority patent/ATE357439T1/de
Priority to ES02758207T priority patent/ES2282446T3/es
Priority to EP02758207A priority patent/EP1401826B1/en
Priority to MXPA03011199A priority patent/MXPA03011199A/es
Priority to KR1020037015833A priority patent/KR100627532B1/ko
Priority to DE60219009T priority patent/DE60219009T2/de
Priority to CA002448058A priority patent/CA2448058C/en
Priority to AU2002325221A priority patent/AU2002325221B2/en
Priority to CNB028111974A priority patent/CN1249052C/zh
Priority to JP2003503620A priority patent/JP4088249B2/ja
Priority to ZA200308781A priority patent/ZA200308781B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
GBGB0113524.3A 2001-06-04 2001-06-04 Pyrazole derivatives Ceased GB0113524D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives
US10/154,585 US6538015B1 (en) 2001-06-04 2002-05-24 Anti-HIV pyrazole derivatives
JP2003503620A JP4088249B2 (ja) 2001-06-04 2002-05-29 Ｈｉｖ逆転写酵素阻害剤としてのピラゾール誘導体
EP02758207A EP1401826B1 (en) 2001-06-04 2002-05-29 Pyrazole derivatives as hiv reverse transcriptase inhibitors
MXPA03011199A MXPA03011199A (es) 2001-06-04 2002-05-29 Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).
DK02758207T DK1401826T3 (da) 2001-06-04 2002-05-29 Pyrazolderivater som inhibitorer for HIV-revers transcriptase
PT02758207T PT1401826E (pt) 2001-06-04 2002-05-29 Derivados de pirazole utilizados como inibidores da transcriptase inversa do vih
AT02758207T ATE357439T1 (de) 2001-06-04 2002-05-29 Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase
ES02758207T ES2282446T3 (es) 2001-06-04 2002-05-29 Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).
BR0210158-0A BR0210158A (pt) 2001-06-04 2002-05-29 Derivados de pirazol como inibidores da transcriptase reversa do hiv
PCT/EP2002/005898 WO2002100853A1 (en) 2001-06-04 2002-05-29 Pyrazole derivatives as hiv reverse transcriptase inhibitors
KR1020037015833A KR100627532B1 (ko) 2001-06-04 2002-05-29 Ｈｉｖ 역전사효소 억제제로서의 피라졸 유도체
DE60219009T DE60219009T2 (de) 2001-06-04 2002-05-29 Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase
CA002448058A CA2448058C (en) 2001-06-04 2002-05-29 Pyrazole derivatives as hiv reverse transcriptase inhibitors
AU2002325221A AU2002325221B2 (en) 2001-06-04 2002-05-29 Pyrazole Derivatives as HIV Reverse Transcriptase Inhibitors
CNB028111974A CN1249052C (zh) 2001-06-04 2002-05-29 作为hiv逆转录酶抑制剂的吡唑衍生物
ZA200308781A ZA200308781B (en) 2001-06-04 2003-11-11 Pyrazole derivatives as HIV reverse transcriptase inhibitors.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives

Publications (1)

Publication Number Publication Date
GB0113524D0 true GB0113524D0 (en) 2001-07-25

Family

ID=9915841

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0113524.3A Ceased GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives

Country Status (17)

Country Link
US (1) US6538015B1 (enExample)
EP (1) EP1401826B1 (enExample)
JP (1) JP4088249B2 (enExample)
KR (1) KR100627532B1 (enExample)
CN (1) CN1249052C (enExample)
AT (1) ATE357439T1 (enExample)
AU (1) AU2002325221B2 (enExample)
BR (1) BR0210158A (enExample)
CA (1) CA2448058C (enExample)
DE (1) DE60219009T2 (enExample)
DK (1) DK1401826T3 (enExample)
ES (1) ES2282446T3 (enExample)
GB (1) GB0113524D0 (enExample)
MX (1) MXPA03011199A (enExample)
PT (1) PT1401826E (enExample)
WO (1) WO2002100853A1 (enExample)
ZA (1) ZA200308781B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
JP4993407B2 (ja) 2004-08-04 2012-08-08 大正製薬株式会社 トリアゾール誘導体
WO2006072833A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
EP1988083B1 (en) 2006-02-03 2014-04-02 Taisho Pharmaceutical Co., Ltd. Triazole derivative
RU2395499C2 (ru) * 2006-02-06 2010-07-27 Тайсо Фармасьютикал Ко., Лтд. Ингибитор связывания сфингозин-1-фосфата
PL2057125T3 (pl) 2006-08-16 2011-09-30 Hoffmann La Roche Nienukleozydowe inhibitory odwrotnej transkryptazy
BRPI0813404A2 (pt) 2007-06-22 2014-12-30 Hoffmann La Roche Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo
SI2177512T1 (sl) 2007-08-01 2012-06-29 Taisho Pharmaceutical Co Ltd Inhibitor vezave S1P1
RU2495878C2 (ru) 2007-12-21 2013-10-20 Ф.Хоффманн-Ля Рош Аг Гетероциклические антивирусные соединения
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
EP2295038B1 (en) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Solid dispersion comprising an anti-HIV agent
ES2528646T3 (es) * 2010-05-20 2015-02-11 Bayer Intellectual Property Gmbh Procedimiento para la fabricación de 1-alquil-3-difluorometil-5-hidroxipirazoles
JP5722891B2 (ja) 2010-07-15 2015-05-27 大日本住友製薬株式会社 ピラゾール化合物
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627423A4 (en) 1992-01-22 1995-02-15 Nissan Chemical Ind Ltd SUBSTITUTED PYRAZOLE DERIVATIVES AND BACTERICIDES FOR AGRICULTURE AND GARDENING.
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
DK0786455T3 (da) 1994-09-26 2004-03-29 Shionogi & Co Imidazolderivater
US5698495A (en) 1995-11-15 1997-12-16 Zeneca Limited Herbicidal substituted pyrazole compounds
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
PT1401826E (pt) 2007-06-19
AU2002325221B2 (en) 2008-07-31
JP4088249B2 (ja) 2008-05-21
CN1527829A (zh) 2004-09-08
WO2002100853A1 (en) 2002-12-19
CN1249052C (zh) 2006-04-05
MXPA03011199A (es) 2004-02-26
US6538015B1 (en) 2003-03-25
DE60219009T2 (de) 2007-12-13
EP1401826A1 (en) 2004-03-31
ATE357439T1 (de) 2007-04-15
JP2004532276A (ja) 2004-10-21
ZA200308781B (en) 2005-02-11
CA2448058C (en) 2008-12-23
CA2448058A1 (en) 2002-12-19
DK1401826T3 (da) 2007-07-30
EP1401826B1 (en) 2007-03-21
BR0210158A (pt) 2004-06-08
DE60219009D1 (de) 2007-05-03
KR20040003050A (ko) 2004-01-07
KR100627532B1 (ko) 2006-09-21
ES2282446T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
YU27203A (sh) Pirazol derivati za tretiranje virusnih oboljenja
GB0113524D0 (en) Pyrazole derivatives
MY146669A (en) Pyrazole derivatives for treating hiv
WO2004071426A3 (en) Compounds for the treatment of viral infection
MXPA05008368A (es) 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
MY136229A (en) Antiviral nucleoside derivatives
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
NO20052739L (no) CCR5-antagonister som medikamenter
WO2002079186A3 (en) Aminopiperidine derivatives as modulators of chemokine receptor activity
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
MXPA05010210A (es) Inhibidores no nucleosidos de transcriptasa inversa para tratar las enfermedades mediadas por el virus de la inmunodeficiencia humana (vih).
AU2003300911A1 (en) Heterocyclic compounds as ccr5 antagonists
MXPA02012409A (es) Derivados de pirrol para tratamiento del sida.
WO2006044968A3 (en) Combination therapy for treating viral infections
GB0223232D0 (en) Chemical compounds
WO2003100036A3 (fr) Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih.
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU2003263455A1 (en) Pyrazole amides for treating hiv infections
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
BR0115476A (pt) Derivados de imidazolona para o tratamento de doenças virais
EA200500287A1 (ru) Производные 4-(3, 5-дицианофенокси)пиразола для применения в качестве модуляторов обратной транскриптазы в лечении, в числе прочего, вич-инфекции
AU2003264940A1 (en) Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases
WO2005028442A3 (en) 2-pyridinone derivatives, having hiv inhibiting properties
AP1846A (en) Pyrazole Derivatives.
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)